222 related articles for article (PubMed ID: 24086071)
81. [Percutaneous radiofrequency ablation of liver cell carcinoma: a current overview].
Kettenbach J; Blum M; Kilanowicz E; Schwaighofer SM; Lammer J
Radiologe; 2004 Apr; 44(4):330-8. PubMed ID: 15045198
[TBL] [Abstract][Full Text] [Related]
82. Laser ablation of hepatocellular carcinoma--a review.
Gough-Palmer AL; Gedroyc WM
World J Gastroenterol; 2008 Dec; 14(47):7170-4. PubMed ID: 19084930
[TBL] [Abstract][Full Text] [Related]
83. Combined therapy of transcatheter hepatic arterial embolization with intratumoral dendritic cell infusion for hepatocellular carcinoma: clinical safety.
Nakamoto Y; Mizukoshi E; Tsuji H; Sakai Y; Kitahara M; Arai K; Yamashita T; Yokoyama K; Mukaida N; Matsushima K; Matsui O; Kaneko S
Clin Exp Immunol; 2007 Feb; 147(2):296-305. PubMed ID: 17223971
[TBL] [Abstract][Full Text] [Related]
84. Efficacy of radiofrequency ablation vs. transcatheter arterial embolization for hepatic hemangiomas.
Li J; Zhang S; Ning C; Li G; Guo S
Eur J Gastroenterol Hepatol; 2024 Jun; 36(6):750-757. PubMed ID: 38555605
[TBL] [Abstract][Full Text] [Related]
85. Successful management of postoperative recurrence of hepatocellular carcinoma with p53 gene therapy combining transcatheter arterial chemoembolization.
Guan YS; Liu Y; Sun L; Li X; He Q
World J Gastroenterol; 2005 Jun; 11(24):3803-5. PubMed ID: 15968745
[TBL] [Abstract][Full Text] [Related]
86. Postoperative adjuvant transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond the Milan criteria: a retrospective analysis.
Dong ZR; Zhang PF; Wang CH; Zhang C; Cai JB; Shi GM; Ke AW; Sun HC; Qiu SJ; Zhou J; Fan J
Am J Cancer Res; 2015; 5(1):450-7. PubMed ID: 25628953
[TBL] [Abstract][Full Text] [Related]
87. New indication for reduction surgery in patients with advanced hepatocellular carcinoma with major vascular involvement.
Gotohda N; Kinoshita T; Konishi M; Nakagohri T; Takahashi S; Furuse J; Ishii H; Yoshino M
World J Surg; 2006 Mar; 30(3):431-8. PubMed ID: 16479350
[TBL] [Abstract][Full Text] [Related]
88. Treatment strategy for hepatocellular carcinoma: expanding the indications for radiofrequency ablation.
Tateishi R; Shiina S; Ohki T; Sato T; Masuzaki R; Imamura J; Goto E; Goto T; Yoshida H; Obi S; Sato S; Kanai F; Yoshida H; Omata M
J Gastroenterol; 2009; 44 Suppl 19():142-6. PubMed ID: 19148809
[TBL] [Abstract][Full Text] [Related]
89. Optimizing Survival Benefit by Surgical Resection by the Seven-Eleven Criteria in Barcelona Clinic Liver Cancer Stage A/B Hepatocellular Carcinoma beyond the Milan Criteria.
Huang CT; Chu YL; Su TH; Huang SC; Tseng TC; Hsu SJ; Liao SH; Hong CM; Liu CH; Yang HC; Liu CJ; Chen PJ; Kao JH
Liver Cancer; 2023 Dec; 12(6):539-549. PubMed ID: 38476293
[TBL] [Abstract][Full Text] [Related]
90. Outcomes of Salvage Surgery Versus Non-Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma After Conversion Therapy with Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Antibody: A Multicenter Retrospective Study.
Wu JY; Wu JY; Fu YK; Ou XY; Li SQ; Zhang ZB; Zhou JY; Li B; Wang SJ; Chen YF; Yan ML
Ann Surg Oncol; 2024 May; 31(5):3073-3083. PubMed ID: 38316732
[TBL] [Abstract][Full Text] [Related]
91. Interventional radiologic treatment of hepatocellular carcinoma-a cost analysis from the payer perspective.
Ray CE; Battaglia C; Libby AM; Prochazka A; Xu S; Funaki B
J Vasc Interv Radiol; 2012 Mar; 23(3):306-14. PubMed ID: 22277271
[TBL] [Abstract][Full Text] [Related]
92. [Management of hepatocellular carcinoma. Where are we now? What's next?].
Taieb J; Barbare JC; Boussaha T; Cunha AS; Baere Td; Rosmorduc O; Zucman-Rossi J; Franco D
Bull Cancer; 2009 Jan; 96(1):19-34. PubMed ID: 19211357
[TBL] [Abstract][Full Text] [Related]
93. Recurrence rates and factors for recurrence after radiofrequency ablation combined with transarterial chemoembolization for hepatocellular carcinoma: a retrospective cohort study.
Kim JH; Yim HJ; Lee KG; Kim SY; Jung ES; Jung YK; Kim JH; Seo YS; Yeon JE; Lee HS; Um SH; Byun KS; Ryu HS
Hepatol Int; 2012 Apr; 6(2):505-10. PubMed ID: 21728030
[TBL] [Abstract][Full Text] [Related]
94. [Comprehensive strategy for extermination of hepatocellular carcinoma--prevention, diagnosis and treatment].
Kamiyama T; Hige S; Sakuhara Y; Chuma M; Shimamura T
Hokkaido Igaku Zasshi; 2011 May; 86(3):127-30. PubMed ID: 21688640
[TBL] [Abstract][Full Text] [Related]
95. Multidisciplinary management of ruptured hepatocellular carcinoma.
Buczkowski AK; Kim PT; Ho SG; Schaeffer DF; Lee SI; Owen DA; Weiss AH; Chung SW; Scudamore CH
J Gastrointest Surg; 2006 Mar; 10(3):379-86. PubMed ID: 16504883
[TBL] [Abstract][Full Text] [Related]
96. [An autopsy case of hepatocellular carcinoma in which sarcoma-like changes and peritoneal dissemination were observed after RFA/TACE treatment].
Obora A; Kojima T; Kato T; Matsuda H; Horie H; Hashimoto H; Fukuta N; Takano Y; Okuda J; Ida K; Saio M
Gan To Kagaku Ryoho; 2009 Jul; 36(7):1183-6. PubMed ID: 19620814
[TBL] [Abstract][Full Text] [Related]
97. Laparoscopic radiofrequency ablation of unresectable hepatocellular carcinoma: long-term follow-up.
Ballem N; Berber E; Pitt T; Siperstein A
HPB (Oxford); 2008; 10(5):315-20. PubMed ID: 18982145
[TBL] [Abstract][Full Text] [Related]
98. Efficacy of surgical resection in management of isolated extrahepatic metastases of hepatocellular carcinoma.
Chan KM; Yu MC; Wu TJ; Lee CF; Chen TC; Lee WC; Chen MF
World J Gastroenterol; 2009 Nov; 15(43):5481-8. PubMed ID: 19916180
[TBL] [Abstract][Full Text] [Related]
99. Comparison of repeated surgical resection and radiofrequency ablation for small recurrent hepatocellular carcinoma after primary resection.
Sun WC; Chen IS; Liang HL; Tsai CC; Chen YC; Wang BW; Lin HS; Chan HH; Hsu PI; Tsai WL; Cheng JS
Oncotarget; 2017 Nov; 8(61):104571-104581. PubMed ID: 29262662
[TBL] [Abstract][Full Text] [Related]
100. Tumoral response factors after radiofrequency ablation of hepatocellular carcinoma in cirrhotic liver.
Calleja Kempin J; Colón Rodríguez A; Muro de la Fuente A; Clemente Ricote G; Prieto Martín M; Santos Castro L; Matilla Peña A; Bañares Cañizares R; Martín Baena D
Rev Esp Enferm Dig; 2005 Oct; 97(10):688-98. PubMed ID: 16351461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
